• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Radioimmunotherapy Market Size, Status and Forecast 2020-2026

report cover
  • 29 October 2020
  • Pharmaceuticals
  • 90 Pages
  • Report Code: 24LS-21661
  • Formate :   
Download FREE Report Sample Download PDF File

United States Radioimmunotherapy -MARKET ADVISORY SERVICES

Global Radioimmunotherapy Scope and Market Size
Radioimmunotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radioimmunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer

Market segment by Application, split into
Tumor Antigens
Radionuclides
Antibodies

Based on regional and country-level analysis, the Radioimmunotherapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Radioimmunotherapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Non Hodgkin Lymphoma (NHL)
1.2.3 Follicular Lymphoma
1.2.4 Solid Tumors
1.2.5 Breast Cancer
1.2.6 Ovarian Cancer
1.2.7 Osteosarcoma
1.2.8 Neuroblastoma
1.2.9 Prostate Cancer
1.3 Market by Application
1.3.1 Global Radioimmunotherapy Market Share by Application: 2020 VS 2026
1.3.2 Tumor Antigens
1.3.3 Radionuclides
1.3.4 Antibodies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Radioimmunotherapy Market Perspective (2015-2026)
2.2 Global Radioimmunotherapy Growth Trends by Regions
2.2.1 Radioimmunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Radioimmunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Radioimmunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Radioimmunotherapy Players by Market Size
3.1.1 Global Top Radioimmunotherapy Players by Revenue (2015-2020)
3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2015-2020)
3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Radioimmunotherapy Revenue
3.4 Global Radioimmunotherapy Market Concentration Ratio
3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2019
3.5 Key Players Radioimmunotherapy Area Served
3.6 Key Players Radioimmunotherapy Product Solution and Service
3.7 Date of Enter into Radioimmunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Radioimmunotherapy Breakdown Data by Type (2015-2026)
4.1 Global Radioimmunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2021-2026)

5 Radioimmunotherapy Breakdown Data by Application (2015-2026)
5.1 Global Radioimmunotherapy Historic Market Size by Application (2015-2020)
5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Radioimmunotherapy Market Size (2015-2026)
6.2 North America Radioimmunotherapy Market Size by Type (2015-2020)
6.3 North America Radioimmunotherapy Market Size by Application (2015-2020)
6.4 North America Radioimmunotherapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Radioimmunotherapy Market Size (2015-2026)
7.2 Europe Radioimmunotherapy Market Size by Type (2015-2020)
7.3 Europe Radioimmunotherapy Market Size by Application (2015-2020)
7.4 Europe Radioimmunotherapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Radioimmunotherapy Market Size (2015-2026)
8.2 China Radioimmunotherapy Market Size by Type (2015-2020)
8.3 China Radioimmunotherapy Market Size by Application (2015-2020)
8.4 China Radioimmunotherapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Radioimmunotherapy Market Size (2015-2026)
9.2 Japan Radioimmunotherapy Market Size by Type (2015-2020)
9.3 Japan Radioimmunotherapy Market Size by Application (2015-2020)
9.4 Japan Radioimmunotherapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Radioimmunotherapy Market Size (2015-2026)
10.2 Southeast Asia Radioimmunotherapy Market Size by Type (2015-2020)
10.3 Southeast Asia Radioimmunotherapy Market Size by Application (2015-2020)
10.4 Southeast Asia Radioimmunotherapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Bayer Healthcare Pharmaceuticals
11.1.1 Bayer Healthcare Pharmaceuticals Company Details
11.1.2 Bayer Healthcare Pharmaceuticals Business Overview
11.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction
11.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020))
11.1.5 Bayer Healthcare Pharmaceuticals Recent Development
11.2 BioSynthema
11.2.1 BioSynthema Company Details
11.2.2 BioSynthema Business Overview
11.2.3 BioSynthema Radioimmunotherapy Introduction
11.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2015-2020)
11.2.5 BioSynthema Recent Development
11.3 Clarity Pharmaceuticals
11.3.1 Clarity Pharmaceuticals Company Details
11.3.2 Clarity Pharmaceuticals Business Overview
11.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction
11.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
11.3.5 Clarity Pharmaceuticals Recent Development
11.4 Curasight
11.4.1 Curasight Company Details
11.4.2 Curasight Business Overview
11.4.3 Curasight Radioimmunotherapy Introduction
11.4.4 Curasight Revenue in Radioimmunotherapy Business (2015-2020)
11.4.5 Curasight Recent Development
11.5 Endocyte
11.5.1 Endocyte Company Details
11.5.2 Endocyte Business Overview
11.5.3 Endocyte Radioimmunotherapy Introduction
11.5.4 Endocyte Revenue in Radioimmunotherapy Business (2015-2020)
11.5.5 Endocyte Recent Development
11.6 Immunomedics
11.6.1 Immunomedics Company Details
11.6.2 Immunomedics Business Overview
11.6.3 Immunomedics Radioimmunotherapy Introduction
11.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2015-2020)
11.6.5 Immunomedics Recent Development
11.7 Molecular Insight Pharmaceuticals
11.7.1 Molecular Insight Pharmaceuticals Company Details
11.7.2 Molecular Insight Pharmaceuticals Business Overview
11.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction
11.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
11.7.5 Molecular Insight Pharmaceuticals Recent Development
11.8 Nordic Nanovector
11.8.1 Nordic Nanovector Company Details
11.8.2 Nordic Nanovector Business Overview
11.8.3 Nordic Nanovector Radioimmunotherapy Introduction
11.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2015-2020)
11.8.5 Nordic Nanovector Recent Development
11.9 PDL Biopharma
11.9.1 PDL Biopharma Company Details
11.9.2 PDL Biopharma Business Overview
11.9.3 PDL Biopharma Radioimmunotherapy Introduction
11.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2015-2020)
11.9.5 PDL Biopharma Recent Development
11.10 Philogen
11.10.1 Philogen Company Details
11.10.2 Philogen Business Overview
11.10.3 Philogen Radioimmunotherapy Introduction
11.10.4 Philogen Revenue in Radioimmunotherapy Business (2015-2020)
11.10.5 Philogen Recent Development
11.11 RadioMedix
10.11.1 RadioMedix Company Details
10.11.2 RadioMedix Business Overview
10.11.3 RadioMedix Radioimmunotherapy Introduction
10.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2015-2020)
10.11.5 RadioMedix Recent Development
11.12 Stella Pharma
10.12.1 Stella Pharma Company Details
10.12.2 Stella Pharma Business Overview
10.12.3 Stella Pharma Radioimmunotherapy Introduction
10.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2015-2020)
10.12.5 Stella Pharma Recent Development
11.13 Telix Pharmaceuticals
10.13.1 Telix Pharmaceuticals Company Details
10.13.2 Telix Pharmaceuticals Business Overview
10.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction
10.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
10.13.5 Telix Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of Non Hodgkin Lymphoma (NHL)

Table 4. Key Players of Follicular Lymphoma

Table 5. Key Players of Solid Tumors

Table 6. Key Players of Breast Cancer

Table 7. Key Players of Ovarian Cancer

Table 8. Key Players of Osteosarcoma

Table 9. Key Players of Neuroblastoma

Table 10. Key Players of Prostate Cancer

Table 11. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 12. Global Radioimmunotherapy Market Size by Regions (US$ Million): 2020 VS 2026

Table 13. Global Radioimmunotherapy Market Size by Regions (2015-2020) (US$ Million)

Table 14. Global Radioimmunotherapy Market Share by Regions (2015-2020)

Table 15. Global Radioimmunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 16. Global Radioimmunotherapy Market Share by Regions (2021-2026)

Table 17. Radioimmunotherapy Market Market Trends

Table 18. Radioimmunotherapy Market Drivers

Table 19. Radioimmunotherapy Market Challenges

Table 20. Radioimmunotherapy Market Restraints

Table 21. Global Radioimmunotherapy Revenue by Players (2015-2020) (US$ Million)

Table 22. Global Radioimmunotherapy Market Share by Players (2015-2020)

Table 23. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2019)

Table 24. Global Radioimmunotherapy by Players Market Concentration Ratio (CR5 and HHI)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Radioimmunotherapy Product Solution and Service

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 29. Global Radioimmunotherapy Market Size Share by Type (2015-2020)

Table 30. Global Radioimmunotherapy Revenue Market Share by Type (2021-2026)

Table 31. Global Radioimmunotherapy Market Size Share by Application (2015-2020)

Table 32. Global Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 33. Global Radioimmunotherapy Market Size Share by Application (2021-2026)

Table 34. North America Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 35. North America Radioimmunotherapy Market Share by Type (2015-2020)

Table 36. North America Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 37. North America Radioimmunotherapy Market Share by Application (2015-2020)

Table 38. North America Radioimmunotherapy Market Size by Country (US$ Million) (2015-2020)

Table 39. North America Radioimmunotherapy Market Share by Country (2015-2020)

Table 40. Europe Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 41. Europe Radioimmunotherapy Market Share by Type (2015-2020)

Table 42. Europe Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 43. Europe Radioimmunotherapy Market Share by Application (2015-2020)

Table 44. Europe Radioimmunotherapy Market Size by Country (US$ Million) (2015-2020)

Table 45. Europe Radioimmunotherapy Market Share by Country (2015-2020)

Table 46. China Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 47. China Radioimmunotherapy Market Share by Type (2015-2020)

Table 48. China Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 49. China Radioimmunotherapy Market Share by Application (2015-2020)

Table 50. China Radioimmunotherapy Market Size by Region (US$ Million) (2015-2020)

Table 51. China Radioimmunotherapy Market Share by Region (2015-2020)

Table 52. Japan Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 53. Japan Radioimmunotherapy Market Share by Type (2015-2020)

Table 54. Japan Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 55. Japan Radioimmunotherapy Market Share by Application (2015-2020)

Table 56. Japan Radioimmunotherapy Market Size by Country (US$ Million) (2015-2020)

Table 57. Japan Radioimmunotherapy Market Share by Country (2015-2020)

Table 58. Southeast Asia Radioimmunotherapy Market Size by Type (2015-2020) (US$ Million)

Table 59. Southeast Asia Radioimmunotherapy Market Share by Type (2015-2020)

Table 60. Southeast Asia Radioimmunotherapy Market Size by Application (2015-2020) (US$ Million)

Table 61. Southeast Asia Radioimmunotherapy Market Share by Application (2015-2020)

Table 62. Southeast Asia Radioimmunotherapy Market Size by Country (US$ Million) (2015-2020)

Table 63. Southeast Asia Radioimmunotherapy Market Share by Country (2015-2020)

Table 64. Bayer Healthcare Pharmaceuticals Company Details

Table 65. Bayer Healthcare Pharmaceuticals Business Overview

Table 66. Bayer Healthcare Pharmaceuticals Product

Table 67. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 68. Bayer Healthcare Pharmaceuticals Recent Development

Table 69. BioSynthema Company Details

Table 70. BioSynthema Business Overview

Table 71. BioSynthema Product

Table 72. BioSynthema Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 73. BioSynthema Recent Development

Table 74. Clarity Pharmaceuticals Company Details

Table 75. Clarity Pharmaceuticals Business Overview

Table 76. Clarity Pharmaceuticals Product

Table 77. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 78. Clarity Pharmaceuticals Recent Development

Table 79. Curasight Company Details

Table 80. Curasight Business Overview

Table 81. Curasight Product

Table 82. Curasight Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 83. Curasight Recent Development

Table 84. Endocyte Company Details

Table 85. Endocyte Business Overview

Table 86. Endocyte Product

Table 87. Endocyte Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 88. Endocyte Recent Development

Table 89. Immunomedics Company Details

Table 90. Immunomedics Business Overview

Table 91. Immunomedics Product

Table 92. Immunomedics Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 93. Immunomedics Recent Development

Table 94. Molecular Insight Pharmaceuticals Company Details

Table 95. Molecular Insight Pharmaceuticals Business Overview

Table 96. Molecular Insight Pharmaceuticals Product

Table 97. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 98. Molecular Insight Pharmaceuticals Recent Development

Table 99. Nordic Nanovector Business Overview

Table 100. Nordic Nanovector Product

Table 101. Nordic Nanovector Company Details

Table 102. Nordic Nanovector Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 103. Nordic Nanovector Recent Development

Table 104. PDL Biopharma Company Details

Table 105. PDL Biopharma Business Overview

Table 106. PDL Biopharma Product

Table 107. PDL Biopharma Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 108. PDL Biopharma Recent Development

Table 109. Philogen Company Details

Table 110. Philogen Business Overview

Table 111. Philogen Product

Table 112. Philogen Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 113. Philogen Recent Development

Table 114. RadioMedix Company Details

Table 115. RadioMedix Business Overview

Table 116. RadioMedix Product

Table 117. RadioMedix Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 118. RadioMedix Recent Development

Table 119. Stella Pharma Company Details

Table 120. Stella Pharma Business Overview

Table 121. Stella Pharma Product

Table 122. Stella Pharma Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 123. Stella Pharma Recent Development

Table 124. Telix Pharmaceuticals Company Details

Table 125. Telix Pharmaceuticals Business Overview

Table 126. Telix Pharmaceuticals Product

Table 127. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (US$ Million)

Table 128. Telix Pharmaceuticals Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Radioimmunotherapy Market Share by Type: 2020 VS 2026

Figure 2. Non Hodgkin Lymphoma (NHL) Features

Figure 3. Follicular Lymphoma Features

Figure 4. Solid Tumors Features

Figure 5. Breast Cancer Features

Figure 6. Ovarian Cancer Features

Figure 7. Osteosarcoma Features

Figure 8. Neuroblastoma Features

Figure 9. Prostate Cancer Features

Figure 10. Global Radioimmunotherapy Market Share by Application: 2020 VS 2026

Figure 11. Tumor Antigens Case Studies

Figure 12. Radionuclides Case Studies

Figure 13. Antibodies Case Studies

Figure 14. Radioimmunotherapy Report Years Considered

Figure 15. Global Radioimmunotherapy Market Size (US$ Million), YoY Growth 2015-2026

Figure 16. Global Radioimmunotherapy Market Share by Regions: 2020 VS 2026

Figure 17. Global Radioimmunotherapy Market Share by Regions (2021-2026)

Figure 18. Global Radioimmunotherapy Market Share by Players in 2019

Figure 19. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2019

Figure 20. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2019

Figure 21. North America Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 22. United States Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 23. Canada Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 24. Europe Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 25. Germany Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. France Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. U.K. Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. Italy Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. Russia Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. Nordic Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. Rest of Europe Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. China Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. Japan Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. South Korea Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. India Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Australia Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. Rest of Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Latin America Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. Mexico Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 42. Brazil Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 43. Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 44. Turkey Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 45. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 46. UAE Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 47. Rest of Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 48. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 49. BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 50. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 51. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 52. Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 53. Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 54. Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 55. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 56. PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 57. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 58. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 59. Stella Pharma Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 60. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2015-2020)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

Bayer Healthcare Pharmaceuticals

BioSynthema

Clarity Pharmaceuticals

Curasight

Endocyte

Immunomedics

Molecular Insight Pharmaceuticals

Nordic Nanovector

PDL Biopharma

Philogen

RadioMedix

Stella Pharma

Telix Pharmaceuticals

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3081

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase